Viking Therapeutics to Report Financial Results for First Quarter ...

Viking Therapeutics Reports Fourth Quarter and Year-End 2023 ...

For the three months ended December 31, 2023, Viking reported a net loss of $24.6 million, or $0.25 per share, compared to a net loss of $19.6 ...

Viking Therapeutics (VKTX) Earnings Date and Reports 2024

Viking Therapeutics released Q3 2024 earnings on October 23, 2024, reporting an EPS of -$0.22, which topped analysts' consensus estimates of -$0.24 by $0.02 ...

Viking Therapeutics to Report Financial Results for Fourth Quarter ...

("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine ...

Viking Therapeutics Reports Third Quarter 2023 Financial Results ...

Strong Quarter-End Cash Position of $376M. During the second quarter, Viking closed a public offering of common stock, which raised gross ...

Viking Therapeutics (VKTX) Q1 2022 Earnings Call Transcript

I'll now go over our financial results for the first quarter ended March 31, 2022. Our research and development expenses for the three months ...

Viking Therapeutics to Report Financial Results for First Quarter ...

SAN DIEGO, April 20, 2023 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company ...

Earnings call: Viking Therapeutics Q3 financials and clinical updates

Viking Therapeutics emphasized its strong cash position, with $930 million in cash and equivalents, and its strategic plans for upcoming ...

Viking Therapeutics' Hot Stock Slips After Latest Obesity Drug Trial ...

Viking Therapeutics shares rose Monday morning before reversing course and declining after reporting the latest results from clinical trials ...

Viking Therapeutics Stock Climbs On Q2 EPS Beat - Benzinga

Viking Therapeutics reports quarterly losses of 20 cents per share which beat the analyst consensus estimate of losses of 27 cents by 25.93% ...

Viking Therapeutics Reports Second Quarter 2023 Financial Results ...

"In the second quarter of 2023 Viking continued to build on the momentum achieved in the first quarter, following the successful Phase 1 results ...

Viking Therapeutics, Inc. (VKTX) Q1 2023 - Earnings Call Transcript

Welcome to the Viking Therapeutics First Quarter 2023 Financial Results Conference Call. At this time, all participants are in a listen-only ...

Viking Therapeutics to Report Financial Results for First Quarter ...

(“Viking”) (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine ...

Viking Dives As Obesity Competition Sabotages Its Novo Beat

Viking Therapeutics' weight-loss pill topped expectations after just four weeks of treatment. But Viking stock pulled back from bullish ...

Viking Therapeutics, Inc. (VKTX) 10-Q Quarterly Report July 2024

Viking Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update · VK2735 to Advance to Phase 3 for Obesity; End- ...

Viking Therapeutics to Announce Q2 2024 Financial Results on July ...

Viking Therapeutics, Inc. (Viking), a clinical-stage biopharmaceutical firm listed on NASDAQ as VKTX, has announced that it will release its financial results ...

Viking Therapeutics to Report Financial Results for Third Quarter ...

ConferenceCall Scheduled for Wednesday, October 23 at 4:30 p.m. Eastern Time SAN DIEGO, Oct. 16, 2024 /PRNewswire/ -- Viking Therapeutics, Inc. ('Viking') ...

Structure Therapeutics Vs. Viking Therapeutics: Which Weight-Loss ...

Like Structure Therapeutics, Viking is a pre-revenue biopharma company that reported its Q1 earnings results on April 24, topping analysts' ...

VKTX Press Release: Viking Therapeutics to Report Financial Resul...

("Viking") (NASDAQ:VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine ...

Mike Millmier on LinkedIn: Viking Therapeutics Reports Second ...

VKTX's rich valuation can actually be attributed to two major compounds in its pipeline that could result in annual company sales of roughly $41 ...

Why Viking's Weight-Loss Drug News Is Weighing on Eli Lilly, Novo ...

... Viking disclosed the results of the first ... "Viking Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update.